ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

ClinicalTrials.gov ID: NCT05323734

Public ClinicalTrials.gov record NCT05323734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC)

Study identification

NCT ID
NCT05323734
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Marinus Pharmaceuticals
Industry
Enrollment
129 participants

Conditions and interventions

Interventions

  • Ganaxolone Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2022
Primary completion
Sep 8, 2024
Completion
Oct 13, 2024
Last update posted
Jul 10, 2025

2022 – 2024

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Arkansas Children's Research Institute Little Rock Arkansas 72202
UCLA Mattel Children's Hospital, TSC Center Los Angeles California 90095
Children's Hospital of Orange County Orange California 92868
University of California, San Diego San Diego California 92123
Childrens Hospital Colorado Aurora Colorado 80045
Nemours Children's Hospital - Delaware Valley Wilmington Delaware 19803
University of Florida Gainesville Gainesville Florida 32608
Nemours Children's Health Jacksonville Florida 32207
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
Mayo Clinic - Rochester Rochester Minnesota 55905
Children's Mercy Hosptial Kansas City Missouri 64108
University of Rochester Medical Center Rochester New York 14642
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Atrium Health/Levine Children's Hospital Charlotte North Carolina 28207
Duke University Medical Center Durham North Carolina 27712
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Penn State Children's Hospital Hershey Pennsylvania 17033
Le Bonheur Children's Hospital Memphis Tennessee 38103
Child Neurology Consultants of Austin (CNCA) Austin Texas 78757
University of Texas Southwestern Medical Center Dallas Texas 75207
McGovern Medical School at the University of Texas Health Science Center Houston Texas 77030
University of Utah Health Care-Pediatric Neurology Salt Lake City Utah 84108
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05323734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05323734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →